MarketScanners

MEIP Catalyst Trade With Technical Set-Up

Long
NASDAQ:MEIP   MEI Pharma, Inc
0
MEI Pharma , Inc. ( MEIP ), will be presenting data on Pracinostat, in combination with azacitidine in patients with advanced myelodysplastic syndrome (MDS) at a poster presentation at the American Society of Hematology Annual Meeting on December 10, 2012.

Stock looks good for at least a $.50 pop

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.